An 18-month-old in London, England, is one of the youngest children to receive gene therapy to treat hearing loss caused by a mutation in the OTOF gene. This gene produces a protein called Otoferlin that allows for communication between cells of the cochlea and the brain.
The recipient received an infusion of a functional copy of the OTOF in her ear. The procedure was completed in just 16 minutes. Reportedly, it only took a few weeks for the child to begin to hear and respond to sounds without the help of her cochlear implant.
References
Afzali K. (2024) Toddler born deaf can hear after gene therapy trial breakthrough her parents call “mind-blowing.”CBS News(accessed May 13, 2024).
Recent Posts
Benefits of Cochlear Implantation and Hearing Preservation for Children with Preoperative Functional Hearing
There are two types of cochlear implants available on the market today. The traditional cochlear implant (CI) employs only electrical stimulation (ES) via an electrode…
In Memoriam: Richard Hayes Wilson
By Robert H. Margolis, PhD Richard H. Wilson, PhD, audiological scientist, teacher, program director, and cherished colleague, passed away October 7. Richard’s footprint on the…
Academy Recognizes First Distinguished Fellows of the American Academy of Audiology (DFAAA)
The American Academy of Audiology is proud to announce the inaugural cohort of Distinguished Fellows of the American Academy of Audiology (DFAAA), a prestigious honor…